Paradromics advances Connect-One trial with MGH and announces five new research platform partners
Summary
Paradromics advanced the Connect-One early feasibility study for their Connexus speech BCI at Massachusetts General Hospital, with principal investigator Leigh Hochberg's team providing expertise from decades of BrainGate research. Simultaneously, Paradromics announced five new institutional research platform partners accessing the Connexus device for collaborative neural data collection, expanding their research footprint beyond the clinical trial sites.
Why it matters
MGH as principal investigator site for Connect-One connects Paradromics to the most experienced clinical BCI team in the world — Leigh Hochberg's group has run BrainGate for 20 years and has unmatched expertise in working with paralyzed patients. The five new research partners strategy creates a collaborative data collection network that will generate the neural datasets needed to train next-generation speech decoders.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial